Catalyst Biosciences To Present At 19th Annual BIO CEO & Investor Conference Post author:Sam Post published:February 2, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Calls AstraZeneca PLC and MedImmune???s Imfinzi a Breakthrough July 30, 2017 Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society September 14, 2017 Exelixis Announces Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update February 27, 2017
Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society September 14, 2017
Exelixis Announces Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update February 27, 2017